150 related articles for article (PubMed ID: 34825790)
1. The benefits of purified cytoplasm of pollen in reducing menopausal symptoms in peri- and post-menopause: an Italian multicenter prospective observational study.
Lello S; Capozzi A; Xholli A; Cagnacci A;
Minerva Obstet Gynecol; 2022 Dec; 74(6):516-521. PubMed ID: 34825790
[TBL] [Abstract][Full Text] [Related]
2. The efficacy of purified pollen extract for reducing vasomotor symptoms in women: a systematic review and meta-analysis.
Acquarulo EL; Hernandez EC; Kodzodziku F; Nemec EC
Menopause; 2024 Feb; 31(2):154-159. PubMed ID: 38194609
[TBL] [Abstract][Full Text] [Related]
3. Non-hormonal Treatments For Menopausal Symptoms and Sleep Disturbances: A Comparison Between Purified Pollen Extracts and Soy Isoflavones.
De Franciscis P; Conte A; Schiattarella A; Riemma G; Cobellis L; Colacurci N
Curr Pharm Des; 2020; 26(35):4509-4514. PubMed ID: 32693763
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of fezolinetant, a neurokinin-3 antagonist, in treating vasomotor symptoms in postmenopausal women: A systematic review and meta-analysis.
Rahman UA; Kashif TB; Usman M; Rana M; Hasanain M; Anjum MU; Cheema HA; Jaffar H; Bhattarai P
Medicine (Baltimore); 2023 Dec; 102(50):e36592. PubMed ID: 38115258
[TBL] [Abstract][Full Text] [Related]
5. Duration of menopausal vasomotor symptoms over the menopause transition.
Avis NE; Crawford SL; Greendale G; Bromberger JT; Everson-Rose SA; Gold EB; Hess R; Joffe H; Kravitz HM; Tepper PG; Thurston RC;
JAMA Intern Med; 2015 Apr; 175(4):531-9. PubMed ID: 25686030
[TBL] [Abstract][Full Text] [Related]
6. Vasomotor symptoms and management of women undergoing treatment for breast cancer: literature review with focus on the therapeutic potential of cytoplasmic pollen extract.
Lello S; Paris I; Cagnacci A; Sartori D; Caruso S; Iop A
Gynecol Endocrinol; 2023 Dec; 39(1):2162035. PubMed ID: 36591791
[TBL] [Abstract][Full Text] [Related]
7. Vasomotor symptoms and neurovegetative comorbidities on the menopause: insights from an Italian quantitative research.
Graziottin A; Banerji V; Hall G
Gynecol Endocrinol; 2019 Sep; 35(9):762-766. PubMed ID: 31266379
[TBL] [Abstract][Full Text] [Related]
8. Morning/evening menopausal formula relieves menopausal symptoms: a pilot study.
Sun J
J Altern Complement Med; 2003 Jun; 9(3):403-9. PubMed ID: 12816628
[TBL] [Abstract][Full Text] [Related]
9. Prospective observational study to evaluate the efficacy and safety of the pollen extract Sérélys
Fait T; Sailer M; Regidor PA
Gynecol Endocrinol; 2019 Apr; 35(4):360-363. PubMed ID: 30741042
[TBL] [Abstract][Full Text] [Related]
10. A systematic review of community pharmacy interventions to improve peri- and post-menopausal health.
Chow H; Righton O; Berry H; Bell Z; Flynn AC
Post Reprod Health; 2024 Mar; 30(1):55-63. PubMed ID: 38185857
[TBL] [Abstract][Full Text] [Related]
11. Finished herbal product as an alternative treatment for menopausal symptoms in climacteric women.
Lai JN; Hwang JS; Chen HJ; Wang JD
J Altern Complement Med; 2005 Dec; 11(6):1075-84. PubMed ID: 16398600
[TBL] [Abstract][Full Text] [Related]
12. A randomized, double-blind, multiple-dose escalation study of a Chinese herbal medicine preparation (Dang Gui Buxue Tang) for moderate to severe menopausal symptoms and quality of life in postmenopausal women.
Wang CC; Cheng KF; Lo WM; Law C; Li L; Leung PC; Chung TK; Haines CJ
Menopause; 2013 Feb; 20(2):223-31. PubMed ID: 22990757
[TBL] [Abstract][Full Text] [Related]
13. The effect of Chinese herbal medicines (CHM) on menopausal symptoms compared to hormone replacement therapy (HRT) and placebo.
Kwee SH; Tan HH; Marsman A; Wauters C
Maturitas; 2007 Sep; 58(1):83-90. PubMed ID: 17689896
[TBL] [Abstract][Full Text] [Related]
14. Femal, a herbal remedy made from pollen extracts, reduces hot flushes and improves quality of life in menopausal women: a randomized, placebo-controlled, parallel study.
Winther K; Rein E; Hedman C
Climacteric; 2005 Jun; 8(2):162-70. PubMed ID: 16096172
[TBL] [Abstract][Full Text] [Related]
15. Night sweats, sleep disturbance, and depression associated with diminished libido in late menopausal transition and early postmenopause: baseline data from the Herbal Alternatives for Menopause Trial (HALT).
Reed SD; Newton KM; LaCroix AZ; Grothaus LC; Ehrlich K
Am J Obstet Gynecol; 2007 Jun; 196(6):593.e1-7; discussion 593.e7. PubMed ID: 17547910
[TBL] [Abstract][Full Text] [Related]
16. Progesterone for treatment of symptomatic menopausal women.
Prior JC
Climacteric; 2018 Aug; 21(4):358-365. PubMed ID: 29962247
[TBL] [Abstract][Full Text] [Related]
17. The effectiveness of sublingual and topical compounded bioidentical hormone replacement therapy in postmenopausal women: an observational cohort study.
Ruiz AD; Daniels KR
Int J Pharm Compd; 2014; 18(1):70-7. PubMed ID: 24881343
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of a non-hormonal treatment, BRN-01, on menopausal hot flashes: a multicenter, randomized, double-blind, placebo-controlled trial.
Colau JC; Vincent S; Marijnen P; Allaert FA
Drugs R D; 2012 Sep; 12(3):107-19. PubMed ID: 22852580
[TBL] [Abstract][Full Text] [Related]
19. Interrupted lullabies: the association between menopausal symptoms and sleep variability in peri- and post-menopausal women.
Ghose SM; Riedy D; Dautovich ND
Women Health; 2023 Feb; 63(2):115-124. PubMed ID: 36587946
[TBL] [Abstract][Full Text] [Related]
20. Effect of desvenlafaxine on mood and climacteric symptoms in menopausal women with moderate to severe vasomotor symptoms.
Cheng RJ; Dupont C; Archer DF; Bao W; Racketa J; Constantine G; Pickar JH
Climacteric; 2013 Feb; 16(1):17-27. PubMed ID: 22646219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
